226 related articles for article (PubMed ID: 17563464)
1. Melanocortin interventions in cachexia: how soon from bench to bedside?
DeBoer MD
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):457-62. PubMed ID: 17563464
[TBL] [Abstract][Full Text] [Related]
2. Cachexia: lessons from melanocortin antagonism.
Deboer MD; Marks DL
Trends Endocrinol Metab; 2006 Jul; 17(5):199-204. PubMed ID: 16750633
[TBL] [Abstract][Full Text] [Related]
3. Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease.
DeBoer MD; Marks DL
Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):459-66. PubMed ID: 16932335
[TBL] [Abstract][Full Text] [Related]
4. Update on melanocortin interventions for cachexia: progress toward clinical application.
DeBoer MD
Nutrition; 2010 Feb; 26(2):146-51. PubMed ID: 20004082
[TBL] [Abstract][Full Text] [Related]
5. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.
Joppa MA; Gogas KR; Foster AC; Markison S
Peptides; 2007 Mar; 28(3):636-42. PubMed ID: 17204351
[TBL] [Abstract][Full Text] [Related]
6. MC4 receptor antagonists: a potential treatment for cachexia.
Foster AC; Chen C; Markison S; Marks DL
IDrugs; 2005 Apr; 8(4):314-9. PubMed ID: 15800806
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cachexia: melanocortin and ghrelin interventions.
Steinman J; DeBoer MD
Vitam Horm; 2013; 92():197-242. PubMed ID: 23601426
[TBL] [Abstract][Full Text] [Related]
8. Central mechanisms controlling appetite and food intake in a cancer setting: an update.
Fletcher AL; Marks DL
Curr Opin Support Palliat Care; 2007 Dec; 1(4):306-11. PubMed ID: 18685380
[TBL] [Abstract][Full Text] [Related]
9. Anticatabolic properties of melanocortin-4 receptor antagonists.
Madison LD; Marks DL
Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):196-200. PubMed ID: 16607116
[TBL] [Abstract][Full Text] [Related]
10. Neural control of the anorexia-cachexia syndrome.
Laviano A; Inui A; Marks DL; Meguid MM; Pichard C; Rossi Fanelli F; Seelaender M
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1000-8. PubMed ID: 18713954
[TBL] [Abstract][Full Text] [Related]
11. [Melanocortin system].
Levitskaia NG; Kamenskiĭ AA
Usp Fiziol Nauk; 2009; 40(1):44-65. PubMed ID: 19326848
[TBL] [Abstract][Full Text] [Related]
12. The role of ghrelin and ghrelin analogues in wasting disease.
Kamiji MM; Inui A
Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):443-51. PubMed ID: 18542005
[TBL] [Abstract][Full Text] [Related]
13. Feeding effects of melanocortin ligands--a historical perspective.
Irani BG; Haskell-Luevano C
Peptides; 2005 Oct; 26(10):1788-99. PubMed ID: 16046247
[TBL] [Abstract][Full Text] [Related]
14. Emergence of ghrelin as a treatment for cachexia syndromes.
DeBoer MD
Nutrition; 2008 Sep; 24(9):806-14. PubMed ID: 18725076
[TBL] [Abstract][Full Text] [Related]
15. Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling.
Mak RH; Cheung W
Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):27-31. PubMed ID: 17143068
[TBL] [Abstract][Full Text] [Related]
16. Appraisal of current and experimental approaches to the treatment of cachexia.
Strasser F
Curr Opin Support Palliat Care; 2007 Dec; 1(4):312-6. PubMed ID: 18685381
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and treatment of anorexia in end-stage renal disease patients on hemodialysis.
Bossola M; Tazza L; Luciani G
J Ren Nutr; 2009 Jan; 19(1):2-9. PubMed ID: 19121762
[TBL] [Abstract][Full Text] [Related]
18. The use of melanocortin antagonists in cachexia of chronic disease.
Scarlett JM; Marks DL
Expert Opin Investig Drugs; 2005 Oct; 14(10):1233-9. PubMed ID: 16185165
[TBL] [Abstract][Full Text] [Related]
19. How does cachexia influence survival in cancer, heart failure and other chronic diseases?
Lainscak M; Podbregar M; Anker SD
Curr Opin Support Palliat Care; 2007 Dec; 1(4):299-305. PubMed ID: 18685379
[TBL] [Abstract][Full Text] [Related]
20. The melanocortin system in leukocyte biology.
Catania A
J Leukoc Biol; 2007 Feb; 81(2):383-92. PubMed ID: 17041004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
